Bruce Neal's Publications

About Bruce Neal's Publications

Executive Director, The George Institute for Global Health, Australia

  • Stakeholder perspectives on Nigeria’s national sodium reduction program: Lessons for implementation and scale-up

    PLOS One Date published:

  • RESISTANT HYPERTENISION: CLINICAL CHARACTERISTICS AND BLOOD PRESSURE CONTROL

    Date published:

  • Canagliflozin Treatment Impact on Collagen Type III Turnover Is Associated with a Reduced Mortality Risk in CANVAS

    Date published:

  • Iron Biomarkers and Effects of Canagliflozin in Patients with Type 2 Diabetes and CKD: A Post Hoc Analysis of the CREDENCE Trial

    Date published:

  • Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients with Type 2 Diabetes and CKD: A Post Hoc Analysis of the CREDENCE Trial

    Date published:

  • Sodium Content and Labelling of Packaged Foods and Beverages in Nigeria: A Cross-Sectional Study

    Nutrients Date published:

  • Randomized trials fit for the 21st century. A joint opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation

    European Heart Journal Date published:

  • Socio-economic difference in purchases of ultra-processed foods in Australia: an analysis of a nationally representative household grocery purchasing panel

    International Journal of Behavioral Nutrition and Physical Activity Date published:

  • Endotrophin is a risk marker of complications in CANagliflozin cardioVascular Assessment Study (CANVAS): a randomized controlled trial

    Cardiovascular Diabetology Date published:

  • Testing the Feasibility and Dietary Impact of a “Produce Prescription” Program for Adults with Undermanaged Type 2 Diabetes and Food Insecurity in Australia

    The Journal of Nutrition Date published:

  • Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria

    Journal of the American College of Cardiology Date published:

  • Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

    The Lancet Date published:

  • Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension - the SaltSwitch Online Grocery Shopping randomized trial

    American Heart Journal Date published:

  • Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk

    Heart Failure Clinics Date published:

  • Estimated Benefits and Risks of Using a Reduced-Sodium, Potassium-Enriched Salt Substitute in India: A Modeling Study

    Hypertension Date published:

  • A Post Hoc Analysis of KidneyIntelX and Cardiorenal Outcomes in Diabetic Kidney Disease

    Kidney360 Date published: